Clinic
Vidant Medical Group LLC
Vidant Medical Group LLC was paid $77.90M by Medicaid between Jan 2018 and Dec 2024, across 366 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoVIDANT MEDICAL GROUP LLC
GREENVILLE, NC 27834
GREENVILLE, NC 27834
33aNPI1477648731assigned 10/04/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$77.90M
24GClaims3,685,452
24DCodes billed366
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in North Carolina
Rank by total paid#2 of 69
Median peer was paid$333K
This provider vs. median234×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 261,363 | $7.06M | |
| 2019 | 296,795 | $9.09M | |
| 2020 | 245,927 | $7.55M | |
| 2021 | 378,962 | $9.98M | |
| 2022 | 747,496 | $13.92M | |
| 2023 | 837,161 | $14.55M | |
| 2024incomplete | 917,748 | $15.75M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 342,078 | 273,990 | $14.61M |
| 99199 | Unlisted special service, procedure or report | 16% | 1,717,585 | 756,147 | $12.11M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 241,210 | 200,662 | $9.10M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.8% | 119,819 | 99,041 | $7.63M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.9% | 109,461 | 95,238 | $4.61M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.5% | 119,609 | 40,632 | $3.49M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.4% | 90,933 | 31,117 | $3.42M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.4% | 15,710 | 13,459 | $1.88M |
| 99223 | Prolong inpt eval add15 m | 2.0% | 20,970 | 15,742 | $1.53M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 16,894 | 14,598 | $1.44M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 13,434 | 12,281 | $1.21M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 19,694 | 15,966 | $1.20M |
354 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 1.5% | 15,387 | $1.18M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.4% | 15,641 | $1.11M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.3% | 23,298 | $1.04M |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.1% | 22,137 | $839K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 8,372 | $750K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 40,331 | $706K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 24,072 | $706K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 23,121 | $684K |
| 99285 | Emergency room visit (most serious) | <1% | 8,262 | $508K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 159,273 | $499K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 10,456 | $381K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 7,889 | $356K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 3,416 | $335K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 4,398 | $335K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,216 | $317K |
| 88307 | <1% | 4,779 | $263K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,844 | $249K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 5,093 | $248K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,808 | $239K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 183 | $237K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 23,754 | $197K |
| 99460 | <1% | 2,180 | $169K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 11,755 | $151K |
| 80053 | Comprehensive metabolic panel | <1% | 16,936 | $143K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,366 | $140K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 9,501 | $135K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 10,650 | $134K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,345 | $126K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,588 | $122K |
| 90474 | <1% | 6,180 | $118K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,609 | $103K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,320 | $103K |
| 95782 | <1% | 224 | $100K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 790 | $99K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,981 | $93K |
| 20610 | <1% | 4,020 | $92K | |
| 99443 | <1% | 2,025 | $87K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,061 | $84K |
| 93000 | <1% | 11,849 | $82K | |
| 88342 | <1% | 2,508 | $72K | |
| 59025 | Fetal non-stress test | <1% | 3,550 | $70K |
| 80061 | Lipid panel | <1% | 5,591 | $68K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 2,031 | $68K |
| 81025 | <1% | 11,726 | $67K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 11,318 | $67K |
| 90837 | Psychotherapy session, about an hour | <1% | 1,189 | $62K |
| 99292 | <1% | 2,001 | $61K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 2,871 | $58K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 760 | $48K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 1,722 | $48K |
| 99442 | <1% | 2,296 | $45K | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 390 | $42K |
| 99205 | Prolong outpt/office vis | <1% | 428 | $42K |
| 96127 | <1% | 17,015 | $40K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 713 | $38K |
| 76801 | <1% | 445 | $37K | |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | <1% | 84 | $34K |
| 90686 | <1% | 8,463 | $33K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 482 | $32K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,173 | $32K |
| 36415 | Collection of venous blood by venipuncture | <1% | 28,114 | $31K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 492 | $30K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 746 | $30K |
| 95720 | <1% | 337 | $30K | |
| D1206 | Topical application of fluoride varnish | <1% | 2,001 | $30K |
| 99462 | <1% | 817 | $28K | |
| 93295 | <1% | 1,409 | $26K | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 716 | $26K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,952 | $25K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 200 | $25K |
| 88341 | <1% | 729 | $24K | |
| 99220 | <1% | 421 | $24K | |
| 11721 | <1% | 3,704 | $24K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 447 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 910 | $22K |
| 76830 | Ultrasound, transvaginal | <1% | 322 | $21K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 297 | $20K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 343 | $20K |
| 11056 | <1% | 2,789 | $19K | |
| 93015 | <1% | 568 | $19K | |
| 99254 | <1% | 144 | $18K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,025 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,306 | $17K |
| 94660 | <1% | 1,450 | $17K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,503 | $15K |
| 99441 | <1% | 1,248 | $15K | |
| 99464 | <1% | 240 | $14K | |
| 92551 | <1% | 12,774 | $14K | |
| 83880 | <1% | 377 | $14K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 527 | $14K |
| 99307 | <1% | 1,600 | $13K | |
| 51798 | <1% | 2,469 | $13K | |
| 99406 | <1% | 1,583 | $13K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 495 | $13K |
| 73630 | <1% | 1,043 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 569 | $13K |
| 90651 | <1% | 1,515 | $12K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 272 | $11K |
| 20553 | <1% | 565 | $11K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 719 | $11K |
| 97161 | <1% | 263 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 726 | $11K |
| 94729 | <1% | 1,004 | $11K | |
| 81003 | <1% | 9,724 | $10K | |
| 99251 | <1% | 412 | $10K | |
| 81002 | <1% | 6,476 | $10K | |
| 99253 | <1% | 127 | $10K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 121 | $10K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 223 | $10K |
| 29581 | <1% | 1,048 | $10K | |
| 88304 | <1% | 1,074 | $9K | |
| 95811 | <1% | 31 | $9K | |
| 95251 | <1% | 418 | $9K | |
| 43264 | <1% | 95 | $9K | |
| 73610 | <1% | 739 | $9K | |
| 95722 | <1% | 60 | $9K | |
| 73560 | <1% | 761 | $8K | |
| 99173 | <1% | 15,234 | $8K | |
| 94727 | <1% | 964 | $8K | |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 45 | $8K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 630 | $7K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 72 | $7K |
| 99381 | <1% | 82 | $7K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 111 | $7K |
| 87428 | <1% | 190 | $7K | |
| 99152 | <1% | 802 | $7K | |
| 95816 | <1% | 192 | $7K | |
| 96161 | <1% | 1,941 | $7K | |
| 54161 | <1% | 17 | $7K | |
| 88141 | <1% | 372 | $6K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 49 | $6K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,660 | $6K |
| 90715 | <1% | 746 | $6K | |
| 95812 | <1% | 64 | $6K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 75 | $6K |
| 88112 | <1% | 193 | $6K | |
| 99497 | <1% | 1,422 | $6K | |
| 85018 | <1% | 3,738 | $6K | |
| 90734 | <1% | 872 | $6K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 252 | $6K |
| 87807 | <1% | 413 | $5K | |
| 94618 | <1% | 482 | $5K | |
| 43235 | <1% | 134 | $5K | |
| 99221 | <1% | 195 | $5K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 460 | $5K |
| 99243 | <1% | 102 | $5K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 108 | $5K |
| 99383 | <1% | 40 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 427 | $5K |
| 98968 | <1% | 206 | $4K | |
| 82962 | <1% | 2,605 | $4K | |
| 87210 | <1% | 1,216 | $4K | |
| 93289 | <1% | 308 | $4K | |
| 82248 | <1% | 841 | $4K | |
| 90697 | <1% | 2,436 | $4K | |
| 94060 | <1% | 276 | $4K | |
| 54150 | <1% | 12 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 196 | $4K |
| 11720 | <1% | 1,128 | $4K | |
| 90473 | <1% | 192 | $4K | |
| 82728 | <1% | 304 | $4K | |
| 85610 | <1% | 1,839 | $4K | |
| 87653 | <1% | 126 | $4K | |
| 80050 | General health panel | <1% | 393 | $3K |
| 72170 | <1% | 339 | $3K | |
| 72100 | <1% | 239 | $3K | |
| 73030 | <1% | 490 | $3K | |
| 85027 | <1% | 528 | $3K | |
| 80305 | <1% | 286 | $3K | |
| 84439 | <1% | 347 | $3K | |
| 76813 | <1% | 41 | $3K | |
| 87430 | <1% | 234 | $3K | |
| 99217 | <1% | 107 | $3K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,975 | $3K |
| 72110 | <1% | 139 | $3K | |
| 99252 | <1% | 82 | $3K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 46 | $3K |
| 73070 | <1% | 247 | $3K | |
| 95819 | <1% | 168 | $3K | |
| 00812 | <1% | 58 | $3K | |
| 93294 | <1% | 328 | $3K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 120 | $2K |
| 82951 | <1% | 182 | $2K | |
| 88173 | <1% | 56 | $2K | |
| 73100 | <1% | 208 | $2K | |
| 93298 | <1% | 283 | $2K | |
| 73552 | <1% | 216 | $2K | |
| 84480 | <1% | 149 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 130 | $2K |
| 83550 | <1% | 254 | $2K | |
| 99219 | <1% | 29 | $2K | |
| 93042 | <1% | 816 | $2K | |
| 81000 | <1% | 1,010 | $2K | |
| 97035 | <1% | 427 | $2K | |
| 73564 | <1% | 143 | $2K | |
| 93296 | <1% | 231 | $2K | |
| 83721 | <1% | 174 | $2K | |
| 93016 | <1% | 190 | $2K | |
| 92015 | Determination of refractive state | <1% | 189 | $2K |
| 99384 | <1% | 13 | $2K | |
| 76857 | <1% | 24 | $2K | |
| 73562 | <1% | 117 | $2K | |
| 99490 | Ccm add 20min | <1% | 195 | $2K |
| 99306 | Prolong nursin fac eval 15m | <1% | 132 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 40 | $1K |
| 92567 | <1% | 132 | $1K | |
| 95806 | <1% | 32 | $1K | |
| 90633 | <1% | 4,760 | $1K | |
| 92579 | <1% | 69 | $1K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 18 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 42 | $1K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 36 | $1K |
| 20552 | <1% | 79 | $1K | |
| 99234 | <1% | 14 | $1K | |
| 90785 | <1% | 312 | $1K | |
| 95886 | <1% | 38 | $1K | |
| 95718 | <1% | 15 | $1K | |
| 93793 | <1% | 1,229 | $1K | |
| 83735 | <1% | 169 | $1K | |
| 80076 | <1% | 186 | $1K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 28 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 107 | $1K |
| 52000 | <1% | 19 | $961.40 | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 33 | $920.87 |
| 81001 | <1% | 335 | $896.12 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 14 | $883.90 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 97 | $880.66 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 19 | $877.07 |
| 43248 | <1% | 18 | $874.98 | |
| 94726 | <1% | 107 | $832.10 | |
| 92552 | <1% | 599 | $830.00 | |
| 90619 | <1% | 352 | $797.51 | |
| 93018 | <1% | 143 | $794.72 | |
| 99226 | <1% | 26 | $784.61 | |
| 90680 | <1% | 3,267 | $781.69 | |
| Q3014 | Telehealth originating site facility fee | <1% | 55 | $745.08 |
| 95115 | <1% | 121 | $733.30 | |
| 94664 | <1% | 170 | $720.52 | |
| 36556 | <1% | 37 | $708.49 | |
| 64400 | <1% | 18 | $706.78 | |
| 83615 | <1% | 107 | $703.28 | |
| 95800 | <1% | 26 | $682.02 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 45 | $660.18 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 1,128 | $651.76 |
| 11057 | <1% | 57 | $640.31 | |
| 73590 | <1% | 65 | $619.02 | |
| 99218 | <1% | 12 | $508.01 | |
| 99463 | <1% | 15 | $495.99 | |
| 90649 | <1% | 58 | $492.60 | |
| 82607 | <1% | 30 | $484.03 | |
| 84450 | <1% | 77 | $483.06 | |
| 93922 | <1% | 14 | $463.73 | |
| A4590 | Special casting material (e.g., fiberglass) | <1% | 23 | $461.40 |
| 99225 | <1% | 27 | $414.43 | |
| 88311 | <1% | 69 | $410.61 | |
| 85014 | <1% | 194 | $389.79 | |
| 84479 | <1% | 61 | $381.14 | |
| 84436 | <1% | 61 | $374.30 | |
| 74328 | <1% | 36 | $371.74 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 36 | $358.66 |
| 84075 | <1% | 56 | $353.66 | |
| 64450 | <1% | 13 | $345.44 | |
| 82247 | <1% | 55 | $343.78 | |
| 82040 | <1% | 55 | $338.98 | |
| 96381 | <1% | 50 | $332.18 | |
| 72040 | <1% | 14 | $311.41 | |
| 73110 | <1% | 19 | $304.91 | |
| 51705 | <1% | 16 | $295.96 | |
| 93228 | <1% | 30 | $288.84 | |
| 90682 | <1% | 19 | $282.90 | |
| 90480 | <1% | 51 | $282.77 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 93 | $269.63 |
| 82274 | <1% | 14 | $257.37 | |
| 99423 | <1% | 16 | $254.79 | |
| 84155 | <1% | 55 | $250.88 | |
| 92083 | <1% | 24 | $250.77 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 14 | $247.99 |
| 90688 | <1% | 1,637 | $244.88 | |
| 94010 | <1% | 30 | $234.90 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 24 | $224.20 |
| 74018 | <1% | 25 | $216.18 | |
| 90670 | <1% | 10,320 | $216.00 | |
| 11055 | <1% | 14 | $204.24 | |
| 90698 | <1% | 1,489 | $202.06 | |
| 90662 | <1% | 1,059 | $191.89 | |
| 93288 | <1% | 13 | $170.10 | |
| 36416 | <1% | 705 | $169.92 | |
| 76937 | <1% | 18 | $168.34 | |
| 99305 | <1% | 16 | $164.02 | |
| 93308 | <1% | 15 | $156.37 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 113 | $150.34 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,367 | $134.25 |
| 93270 | <1% | 14 | $131.92 | |
| 92060 | <1% | 13 | $130.01 | |
| 90656 | <1% | 646 | $123.61 | |
| 92134 | <1% | 12 | $119.30 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 312 | $111.48 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 16 | $109.88 |
| 96160 | <1% | 26 | $99.90 | |
| 88302 | <1% | 21 | $94.97 | |
| 83540 | <1% | 13 | $81.86 | |
| 99000 | <1% | 1,467 | $63.00 | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 13 | $57.40 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 20 | $53.80 |
| 99153 | Mod sedat endo service >5yrs | <1% | 29 | $53.10 |
| 82947 | <1% | 13 | $49.65 | |
| 93321 | <1% | 15 | $46.61 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 13 | $46.59 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 141 | $40.07 |
| 3077F | <1% | 531 | $25.00 | |
| 3080F | <1% | 73 | $25.00 | |
| 90672 | <1% | 316 | $23.64 | |
| 93325 | <1% | 15 | $22.04 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 96 | $21.33 |
| 94760 | <1% | 394 | $20.80 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 33 | $19.60 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $11.88 |
| J3490 | Unclassified drugs | <1% | 1,740 | $10.28 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 260 | $2.80 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 23 | $0.04 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 14 | $0.04 |
| 1160F | 0% | 16,168 | $0.00 | |
| 3078F | 0% | 5,450 | $0.00 | |
| 90681 | 0% | 2,636 | $0.00 | |
| 90685 | 0% | 836 | $0.00 | |
| 90648 | 0% | 742 | $0.00 | |
| 90710 | 0% | 2,462 | $0.00 | |
| 90621 | 0% | 40 | $0.00 | |
| 90700 | 0% | 242 | $0.00 | |
| 3051F | 0% | 17 | $0.00 | |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | 0% | 337 | $0.00 |
| 90707 | 0% | 280 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 14 | $0.00 |
| 90687 | 0% | 20 | $0.00 | |
| 82948 | 0% | 14 | $0.00 | |
| 3046F | 0% | 16 | $0.00 | |
| 90655 | 0% | 15 | $0.00 | |
| 90647 | 0% | 4,026 | $0.00 | |
| 90716 | 0% | 319 | $0.00 | |
| 3074F | 0% | 6,111 | $0.00 | |
| 4010F | 0% | 883 | $0.00 | |
| 90744 | 0% | 398 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 712 | $0.00 |
| 3079F | 0% | 1,555 | $0.00 | |
| 90677 | 0% | 1,726 | $0.00 | |
| 90694 | 0% | 193 | $0.00 | |
| 90723 | 0% | 4,467 | $0.00 | |
| 0503F | 0% | 67 | $0.00 | |
| 90696 | 0% | 606 | $0.00 | |
| 3044F | 0% | 605 | $0.00 | |
| 3075F | 0% | 271 | $0.00 | |
| 99172 | 0% | 94 | $0.00 | |
| 3052F | 0% | 12 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 87 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARTHOLOMEW, ANTHONY (VP OPERATIONS OF ECU HEALTH PHYSICI)